Literature DB >> 7918697

Impaired interhemispheric integration in brain oxygenation and hemodynamics in schizophrenia.

F Okada1, Y Tokumitsu, Y Hoshi, M Tamura.   

Abstract

We examined 38 patients with chronic schizophrenia to find and qualify disturbances in interhemispheric integration in brain oxygen metabolism and hemodynamics during a psychological task. A group of thirty-eight age- and sex-matched healthy volunteers were monitored as controls. Multi channel near-infrared (NIR) spectrophotometry was used to observed real-time alterations in cerebral oxygenation in areas of both hemispheres of the forebrain adjacent to the forehead during the mirror drawing task (MDT). In response to MDT normal volunteers showed distinct and well-integrated patterns of changes in oxygenated hemoglobin Hb, deoxygenated Hb, and blood volume total Hb. On the other hand, half the schizophrenics showed dysregulated patterns between hemispheres which never appeared in normal volunteers. Certain schizophrenic symptoms may be related to defective interhemispheric integration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918697     DOI: 10.1007/bf02279807

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  48 in total

1.  Growth hormone and cortisol responses to psychological stress: comparison of normal and neurotic subjects.

Authors:  S Miyabo; T Hisada; T Asato; N Mizushima; K Ueno
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

2.  Characterization of the near infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation.

Authors:  S Wray; M Cope; D T Delpy; J S Wyatt; E O Reynolds
Journal:  Biochim Biophys Acta       Date:  1988-03-30

3.  Quantitation of absolute concentration change in scattering media by the time-resolved microscopic Beer-Lambert law.

Authors:  M Oda; Y Yamashita; G Nishimura; M Tamura
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

4.  Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease.

Authors:  T J Crow; J Ball; S R Bloom; R Brown; C J Bruton; N Colter; C D Frith; E C Johnstone; D G Owens; G W Roberts
Journal:  Arch Gen Psychiatry       Date:  1989-12

5.  Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.

Authors:  G P Reynolds; C Czudek; H B Andrews
Journal:  Biol Psychiatry       Date:  1990-05-01       Impact factor: 13.382

6.  Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.

Authors:  E J Bartlett; A Wolkin; J D Brodie; E M Laska; A P Wolf; M Sanfilipo
Journal:  Psychiatry Res       Date:  1991-10       Impact factor: 3.222

7.  Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics.

Authors:  R E Gur; B E Skolnick; R C Gur; S Caroff; W Rieger; W D Obrist; D Younkin; M Reivich
Journal:  Arch Gen Psychiatry       Date:  1983-11

8.  Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia.

Authors:  R J Mathew; W H Wilson; S R Tant; L Robinson; R Prakash
Journal:  Arch Gen Psychiatry       Date:  1988-06

9.  Gender- and handedness-related differences of forebrain oxygenation and hemodynamics.

Authors:  F Okada; Y Tokumitsu; Y Hoshi; M Tamura
Journal:  Brain Res       Date:  1993-01-22       Impact factor: 3.252

10.  Corpus callosum thickness in chronic schizophrenia.

Authors:  L B Bigelow; H A Nasrallah; F P Rauscher
Journal:  Br J Psychiatry       Date:  1983-03       Impact factor: 9.319

View more
  8 in total

1.  Dynamic physiological modeling for functional diffuse optical tomography.

Authors:  Solomon Gilbert Diamond; Theodore J Huppert; Ville Kolehmainen; Maria Angela Franceschini; Jari P Kaipio; Simon R Arridge; David A Boas
Journal:  Neuroimage       Date:  2005-10-20       Impact factor: 6.556

2.  Localized near-infrared spectroscopy and functional optical imaging of brain activity.

Authors:  M Tamura; Y Hoshi; F Okada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-06-29       Impact factor: 6.237

3.  Reducing motion artifacts for long-term clinical NIRS monitoring using collodion-fixed prism-based optical fibers.

Authors:  Meryem A Yücel; Juliette Selb; David A Boas; Sydney S Cash; Robert J Cooper
Journal:  Neuroimage       Date:  2013-06-22       Impact factor: 6.556

4.  Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. Part VI. Evaluation of psychomotor training programs in schizophrenic patients.

Authors:  W Günther; P Streck; N Müller; G R Mair; E Kalischek; W Bender; R Günther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 5.  HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain.

Authors:  Theodore J Huppert; Solomon G Diamond; Maria A Franceschini; David A Boas
Journal:  Appl Opt       Date:  2009-04-01       Impact factor: 1.980

6.  Visuospatial task-related prefrontal activity is correlated with negative symptoms in schizophrenia.

Authors:  Adrian Curtin; Junfeng Sun; Qiangfeng Zhao; Banu Onaral; Jijun Wang; Shanbao Tong; Hasan Ayaz
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

Review 7.  Event-related potentials (ERPs) and hemodynamic (functional near-infrared spectroscopy, fNIRS) as measures of schizophrenia deficits in emotional behavior.

Authors:  Michela Balconi; Simone Tirelli; Alessandra Frezza
Journal:  Front Psychol       Date:  2015-11-03

Review 8.  Near-infrared spectroscopy in schizophrenia: a possible biomarker for predicting clinical outcome and treatment response.

Authors:  Shinsuke Koike; Yukika Nishimura; Ryu Takizawa; Noriaki Yahata; Kiyoto Kasai
Journal:  Front Psychiatry       Date:  2013-11-14       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.